Squarepoint
PCVX icon

Squarepoint’s Vaxcyte PCVX Stock Holding History

Squarepoint’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$388K Buy
+6,822
New +$398K ﹤0.01% 3580
2025
Q3 		– Sell
-14,862
Closed -$483K – 4828
2025
Q2 		$483K Sell
14,862
-330,020
-96% -$10.8M ﹤0.01% 3313
2025
Q1 		$13M Sell
344,882
-31,964
-8% -$2.56M 0.02% 901
2024
Q4 		$30.8M Buy
376,846
+313,354
+494% +$31.1M 0.03% 561
2024
Q3 		$7.26M Buy
63,492
+40,136
+172% +$3.62M 0.01% 1166
2024
Q2 		$1.76M Buy
+23,356
New +$1.59M ﹤0.01% 2143
2023
Q3 		– Sell
-5,140
Closed -$257K – 4120
2023
Q2 		$257K Sell
5,140
-20,029
-80% -$949K ﹤0.01% 3063
2023
Q1 		$943K Sell
25,169
-3,874
-13% -$164K ﹤0.01% 1936
2022
Q4 		$1.39M Buy
29,043
+20,000
+221% +$785K 0.01% 1595
2022
Q3 		$217K Buy
+9,043
New +$229K ﹤0.01% 2649
2021
Q3 		– Sell
-16,504
Closed -$372K – 3303
2021
Q2 		$372K Buy
+16,504
New +$338K ﹤0.01% 2370
2021
Q1 		– Sell
-11,233
Closed -$298K – 3498
2020
Q4 		$298K Buy
+11,233
New +$418K ﹤0.01% 2207

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Squarepoint's PCVX Position: Q3 2026 in Review

Squarepoint opened a new position in Vaxcyte (PCVX) in Q3 2026: 6,822 shares worth $388K. The stake represents ﹤0.01% of the portfolio and ranks #3580 among its holdings. This is a return to the name: Squarepoint previously reported a position in PCVX as recently as Q2 2025.

Squarepoint first reported a position in PCVX in Q4 2020 and has held it in 12 quarters since. The position peaked at $30.8M in Q4 2024. 202 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Squarepoint held 6,822 shares of Vaxcyte worth $388K as of Q3 2026.
  • Vaxcyte was a new Squarepoint position in Q3 2026.
  • Vaxcyte made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3580 holding.
  • Squarepoint first reported a position in Vaxcyte in Q4 2020 and has held it in 12 quarters since.
  • Squarepoint's Vaxcyte position peaked at $30.8M in Q4 2024.
  • 202 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.